Abdominal vagal signalling: A novel role for cholecystokinin in circulatory control?

Brain Research Reviews

Volumn 59, Issue 1, 2008, Pages 140-154

  Sartor, Daniela M ^a   Verberne, Anthony J M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Blood flow; Cholecystokinin; Gastrointestinal; Rostroventrolateral medulla; Sympathetic; Vagus

Indexed keywords

ANGIOPEPTIN; BEMESETRON; CHOLECYSTOKININ; DEVAZEPIDE; DIHYDROERGOTAMINE; GASTROINTESTINAL HORMONE; SEROTONIN; SEROTONIN 3 AGONIST; TETRODOTOXIN;

ABDOMEN; ADRENERGIC SYSTEM; BIOLOGICAL ACTIVITY; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR REFLEX; CELL LINE; CIRCULATION; COMPARATIVE STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROPHYSIOLOGY; ENTEROENDOCRINE CELL; FEEDING; GASTROINTESTINAL DISEASE; HUMAN; HYPOTENSION; INTESTINE BLOOD FLOW; INTESTINE INNERVATION; INTESTINE MUCOSA; MEDULLA OBLONGATA; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PARACRINE SIGNALING; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; SKELETAL MUSCLE; VAGUS NERVE STIMULATION; VASODILATATION; VASOMOTOR REFLEX;

ANIMALS; CARDIOVASCULAR SYSTEM; CHOLECYSTOKININ; EFFERENT PATHWAYS; GASTROINTESTINAL TRACT; HUMANS; MEDULLA OBLONGATA; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 53749102698     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.07.002     Document Type: Review

References (207)

1. Ahlman H., Dahlstrom A., Kewenter J., and Lundberg J. Vagal influence on serotonin concentration in enterochromaffin cells in the cat. Acta Physiol. Scand. 97 (1976) 362-368
2. Aja S.M., Barrett J.A., and Gietzen D.W. CCK(A) and 5-HT3 receptors interact in anorectic responses to amino acid deficiency. Pharmacol. Biochem. Behav. 62 (1999) 487-491
3. Andrews P.L., Bingham S., and Davis C.J. Retching evoked by stimulation of abdominal vagal afferents in the anaesthetized ferret. J. Physiol. (Lond.) 358 (1985) 103P
4. Andrews P.L.R., and Lawes I.N.C. A protective role for vagal afferents: an hypothesis. In: Ritter S., et al. (Ed). Neuroanatomy and Physiology of Abdominal Vagal Afferents (1992), CRC Press, Boca Raton 279-302
5. Aronow W.S., and Ahn C. Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents. J. Am. Geriatr. Soc. 45 (1997) 1051-1053
6. Aviado D.M., and Guevara Aviado D. The Bezold-Jarisch reflex. A historical perspective of cardiopulmonary reflexes. Ann. N. Y. Acad. Sci. 940 (2001) 48-58
7. Bago M., and Dean C. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT1A receptors in the RVLM. Am. J. Physiol. 280 (2001) R976-R984
8. Barman S.M., Phillips S.W., and Gebber G.L. Medullary lateral tegmental field mediates the cardiovascular but not respiratory component of the Bezold-Jarisch reflex in the cat. Am. J. Physiol. 289 (2005) R1693-R1702
9. Beinfeld M.C. An introduction to neuronal cholecystokinin. Peptides 22 (2001) 1197-1200
10. Berthoud H.R., and Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat. 156 (1996) 123-131
11. Berthoud H.R., and Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 85 (2000) 1-17
12. Biber B. Vasodilator mechanisms in the small intestine. An experimental study in the cat. Acta Physiol. Scand. Suppl. 401 (1973) 1-31
13. Biber B., Lundgren O., and Svanvik J. Studies on the intestinal vasodilatation observed after mechanical stimulation of the mucosa of the gut. Acta Physiol. Scand. 82 (1971) 177-190
14. Biber B., Fara J., and Lundgren O. Vascular reactions in the small intestine during vasodilatation. Acta Physiol. Scand. 89 (1973) 449-456
15. Billig I., Yates B.J., and Rinaman L. Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am. J. Physiol. 281 (2001) R1243-R1255
16. Blackshaw L.A., and Grundy D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J. Auton. Nerv. Syst. 31 (1990) 191-201
17. Blackshaw L.A., and Grundy D. Locally and reflexly mediated effects of cholecystokinin-octapeptide on the ferret stomach. J. Auton. Nerv. Syst. 36 (1991) 129-137
18. Blackshaw L.A., and Grundy D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J. Auton. Nerv. Syst. 45 (1993) 41-50
19. Blackshaw L.A., Grundy D., and Scratcherd T. Involvement of gastrointestinal mechano-and intestinal chemoreceptors in vagal reflexes: an electrophysiological study. J. Auton. Nerv. Syst. 18 (1987) 225-234
20. Blessing W.W. The lower brainstem and bodily homeostasis (1997), Oxford University Press, New York
21. Booth C.E., Kirkup A.J., Hicks G.A., Humphrey P.P., and Grundy D. Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 121 (2001) 358-369
22. Broberger C., Holmberg K., Shi T.J., Dockray G., and Hokfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res. 903 (2001) 128-140
23. Buller K.M., and Day T.A. Involvement of medullary catecholamine cells in neuroendocrine responses to systemic cholecystokinin. J. Neuroendocrinol. 8 (1996) 819-824
24. Burton-Freeman B., Gietzen D.W., and Schneeman B.O. Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats. Am. J. Physiol. 276 (1999) R429-R434
25. Cao W.H., and Morrison S.F. Responses of adrenal sympathetic preganglionic neurons to stimulation of cardiopulmonary receptors. Brain Res. 887 (2000) 46-52
26. Carrive P., and Bandler R. Viscerotopic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal grey: a correlative functional and anatomical study. Brain Res. 541 (1991) 206-215
27. Carrive P., Bandler R., and Dampney R.A. Anatomical evidence that hypertension associated with the defence reaction in the cat is mediated by a direct projection from a restricted portion of the midbrain periaqueductal grey to the subretrofacial nucleus of the medulla. Brain Res. 460 (1988) 339-345
28. Carrive P., Bandler R., and Dampney R.A. Viscerotopic control of regional vascular beds by discrete groups of neurons within the midbrain periaqueductal gray. Brain Res. 493 (1989) 385-390
29. Chen S., and Aston-Jones G. Anatomical evidence for inputs to ventrolateral medullary catecholaminergic neurons from the midbrain periaqueductal gray of the rat. Neurosci. Lett. 195 (1995) 140-144
30. Chen L.W., Rao Z.R., and Shi J.W. Catecholaminergic neurons in the nucleus tractus solitarii which send their axons to the midbrain periaqueductal gray express Fos protein after noxious stimulation of the stomach: a triple labeling study in the rat. Neurosci. Lett. 189 (1995) 179-181
31. Chou C.C., Hsieh C.P., and Dabney J.M. Comparison of vascular effects of gastrointestinal hormones on various organs. Am. J. Physiol. 232 (1977) H103-H109
32. Cooper S.J., Dourish C.T., and Clifton P.G. CCK antagonists and CCK-monoamine interactions in the control of satiety. Am. J. Clin. Nutr. 55 (1992) 291S-295S
33. Corp E.S., McQuade J., Moran T.H., and Smith G.P. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res. 623 (1993) 161-166
34. Crawley J.N. Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?. Ann. N. Y. Acad. Sci. 448 (1985) 1-8
35. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
36. Daughters R.S., Hofbauer R.D., Grossman A.W., Marshall A.M., Brown E.M., Hartman B.K., and Faris P.L. Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla. Peptides 22 (2001) 1331-1338
37. Davison J.S., and Clarke G.D. Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors. Am. J. Physiol. 255 (1988) G55-G61
38. Dawes G.S., and Comroe Jr. J.H. Chemoreflexes from the heart and lungs. Physiol. Rev. 34 (1954) 167-201
39. Day H.E., McKnight A.T., Poat J.A., and Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33 (1994) 719-727
40. Di Francesco V., Zamboni M., Dioli A., Zoico E., Mazzali G., Omizzolo F., Bissoli L., Solerte S.B., Benini L., and Bosello O. Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 1581-1585
41. Dockray G.J. Immunochemical evidence of cholecystokinin-like peptides in brain. Nature 264 (1976) 568-570
42. Eastwood C., Maubach K., Kirkup A.J., and Grundy D. The role of endogenous cholecystokinin in the sensory transduction of luminal nutrient signals in the rat jejunum. Neurosci. Lett. 254 (1998) 145-148
43. Ek M., Kurosawa M., Lundeberg T., and Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 18 (1998) 9471-9479
44. Essex H.E., Herrick J.R., Baldes E.J., and Mann E.J. Blood flow on the circumflex branch of the left coronary artery of the intact dog. Am. J. Physiol. 117 (1936) 271-279
45. Fagius J. Sympathetic nerve activity in metabolic control-some basic concepts. Acta Physiol. Scand. 177 (2003) 337-343
46. Fara J.W., and Madden K.S. Effect of secretin and cholecystokinin on small intestinal blood flow distribution. Am. J. Physiol. 229 (1975) 1365-1370
47. Farkas E., Jansen A.S., and Loewy A.D. Periaqueductal gray matter input to cardiac-related sympathetic premotor neurons. Brain. Res. 792 (1998) 179-192
48. Fink H., Rex A., Voits M., and Voigt J.P. Major biological actions of CCK- a critical evaluation of research findings. Exp. Brain Res. 123 (1998) 77-83
49. Fozard J.R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. N.-S. Arch. Pharmacol. 326 (1984) 36-44
50. Fraser K.A., and Davison J.S. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp. Physiol. 77 (1992) 225-228
51. Frey P. Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment. Eur. J. Pharmacol. 95 (1983) 87-92
52. Gallavan Jr. R.H., and Chou C.C. Possible mechanisms for the initiation and maintenance of postprandial intestinal hyperemia. Am. J. Physiol. 249 (1985) G301-G308
53. Gentilcore D., Jones K.L., O'Donovan D.G., and Horowitz M. Postprandial hypotension- novel insights into pathophysiology and therapeutic implications. Curr. Vasc. Pharmacol. 4 (2006) 161-171
54. Gibbins I.L., Furness J.B., and Costa M. Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig. Cell Tissue Res. 248 (1987) 417-437
55. Gieroba Z.J., Messenger J.P., and Blessing W.W. Abdominal vagal inputs to catecholamine neurons in the ventrolateral medulla. Clin. Exp. Hypertens. 17 (1995) 237-250
56. Gigoux V., Escrieut C., Silvente-Poirot S., Maigret B., Gouilleux L., Fehrentz J.A., Gully D., Moroder L., Vaysse N., and Fourmy D. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J. Biol. Chem. 273 (1998) 14380-14386
57. Glatzle J., Kreis M.E., Kawano K., Raybould H.E., and Zittel T.T. Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors. Am. J. Physiol. 281 (2001) R222-R229
58. Goehler L.E., Gaykema R.P.A., Hansen M.K., Anderson K., Maier S.F., and Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 85 (2000) 49-59
59. Gores G.J., LaRusso N.F., and Miller L.J. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am. J. Physiol. 250 (1986) G344-G349
60. Gores G.J., Miller L.J., and LaRusso N.F. Hepatic processing of cholecystokinin peptides. II. Cellular metabolism, transport, and biliary excretion. Am. J. Physiol. 250 (1986) G350-G356
61. Granger D.N., Richardson P.D.I., Kvietys P.R., and Mortillaro N.A. Intestinal blood flow. Gastroenterology 78 (1980) 837-863
62. Granger D.N., Kvietys P.R., Korthuis R.J., and Premen A.J. Microcirculation of the intestinal mucosa. In: Schultz S.C., et al. (Ed). Handbook of Physiology vol. 1 (1989), Oxford University Press, New York
63. Green D.W., Gomez G., and Greeley Jr. G.H. Gastrointestinal peptides. Gastroenterol. Clin. N. Am. 18 (1989) 695-733
64. Guth P.H., and Smith E. Neural control of gastric mucosal blood flow in the rat. Gastroenterology 69 (1975) 935-940
65. Guth P.H., Leung F.W., and Kauffman Jr. G.L. Physiology of gastric circulation. In: Schultz S.C., et al. (Ed). Handbook of Physiology vol. 1 (1989), Oxford University Press, New York
66. Guyenet P.G. The sympathetic control of blood pressure. Nat. Rev., Neurosci. 7 (2006) 335-346
67. Guyenet P.G., Filtz T.M., and Donaldson S.R. Role of excitatory amino acids in rat vagal and sympathetic baroreflexes. Brain Res. 407 (1987) 272-284
68. Guyton A.C., and Hall J.E. Textbook of Medical Physiology (1996), W.B. Saunders, Philadelphia
69. Harper A.A., and Raper H.S. Pancreozymin, a stimulant of secretion of pancreatic enzymes in extracts of the small intestine. J. Physiol. (Lond.) 102 (1943) 115
70. 3 receptors participate in CCK-induced suppression of food intake by delaying gastric emptying. Am. J. Physiol. 287 (2004) R817-R823
71. Hayes M.R., Savastano D.M., and Covasa M. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors. Physiol. Behav. 82 (2004) 663-669
72. Heinemann A., Jocic M., Holzer-Petsche U., Petho G., Peskar B.M., Horwell D.C., and Holzer P. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Br. J. Pharmacol. 116 (1995) 2274-2278
73. Heinemann A., Jocic M., Peskar B.M., and Holzer P. CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am. J. Physiol. 270 (1996) G253-G258
74. Herzig K.H. Cholecystokinin-and secretin-releasing peptides in the intestine- a new regulatory interendocrine mechanism in the gastrointestinal tract. Regul. Pept. 73 (1998) 89-94
75. Herzig K.H., Schon I., Tatemoto K., Ohe Y., Li Y., Folsch U.R., and Owyang C. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc. Nat. Acad. Sci. U. S. A. 93 (1996) 7927-7932
76. Hillsley K., and Grundy D. Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J. Physiol. (Lond.) 509 Pt 3 (1998) 717-727
77. Hillsley K., and Grundy D. Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci. Lett. 255 (1998) 63-66
78. Holzer P. Local microcirculatory reflexes and afferent signalling in response to gastric acid challenge. Gut 47 Suppl 4 (2000) iv46-iv48
79. Ivy A.C. A hormone mechanism for gallbladder contraction and evacuation. Am. J. Physiol. 65 (1928) 599
80. Iwase M., Uchizono Y., Nakamura U., Nohara S., and Iida M. Effect of exogenous cholecystokinin on islet blood flow in anesthetized rats. Regul. Peptides 116 (2003) 87-93
81. Jansen R.W., and Hoefnagels W.H. Hormonal mechanisms of postprandial hypotension. J. Am. Geriatr. Soc. 39 (1991) 1201-1207
82. Janssen P.J., Gardiner S.M., Compton A.M., and Bennett T. Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br. J. Pharmacol. 102 (1991) 123-134
83. Jansen R.W., Connelly C.M., Kelley-Gagnon M.M., Parker J.A., and Lipsitz L.A. Postprandial hypotension in elderly patients with unexplained syncope. Arch. Intern. Med. 155 (1995) 945-952
84. Jodal M., and Lundgren O. Neurohormonal control of gastrointestinal blood flow. In: Schultz S.C., et al. (Ed). Handbook of Physiology (1989), Oxford University Press, New York
85. Kinsella S.M., and Tuckey J.P. Perioperative bradycardia and asystole: relationship to vasovagal syncope and the Bezold-Jarisch reflex. Br. J. Anaesth. 86 (2001) 859-868
86. Koyama S., Fujita T., Shibamoto T., Matsuda Y., Uematsu H., and Jones R.O. Contribution of baroreceptor reflexes to blood pressure and sympathetic responses to cholecystokinin and vasoactive intestinal peptide in anesthetized dogs. Eur. J. Pharmacol. 175 (1990) 245-251
87. Krayer O. The history of the Bezold-Jarisch effect. N.-S. Arch. Exp. Path. Pharm. 240 (1961) 361-368
88. Kurosawa M., Uvnas-Moberg K., Miyasaka K., and Lundeberg T. Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. J. Auton. Nerv. Syst. 62 (1997) 72-78
89. Lal S., Kirkup A.J., Brunsden A.M., Thompson D.G., and Grundy D. Vagal afferent responses to fatty acids of different chain length in the rat. Am. J. Physiol. 281 (2001) G907-G915
90. Lankisch T.O., Tsunoda Y., Lu Y., and Owyang C. Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia. Am. J. Physiol. 282 (2002) G1002-G1008
91. Ledesma de Paolo M.I., Celener Gravelle F.P., Celener D., Gonzalez E., Rosembeck G., Bandi J.C., and Fernandez L.B. Influence of VIP on the number of enterochromaffin and mucosal mast cells in the colon of the rat. Regul. Pept. 39 (1992) 191-200
92. Lewis L.D., and Williams J.A. Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am. J. Physiol. 258 (1990) G512-G518
93. Li Y., and Owyang C. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats. Gastroenterology 107 (1994) 525-531
94. Li B.H., and Rowland N.E. Effects of vagotomy on cholecystokinin-and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain. Brain Res. Bull. 37 (1995) 589-593
95. Li Y., and Owyang C. Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat. J. Physiol. (Lond.) 494 (1996) 773-782
96. Li Y., and Owyang C. Peptone stimulates CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons. J. Clin. Invest. 97 (1996) 1463-1470
97. Li P., Lee K.Y., Chang T.M., and Chey W.Y. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats. Am. J. Physiol. 259 (1990) G960-G965
98. Li Y., Hao Y., and Owyang C. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am. J. Physiol. 273 (1997) G679-G685
99. Li Y., Zhu J., and Owyang C. Electrical physiological evidence for highand low-affinity vagal CCK-A receptors. Am. J. Physiol. 277 (1999) G469-G477
100. Li Y., Hao Y., and Owyang C. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J. Clin. Invest. 105 (2000) 351-359
101. Li Y., Hao Y., Zhu J., and Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 118 (2000) 1197-1207
102. Li Y., Wu X.Y., and Owyang C. Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones. J. Physiol. (Lond.) 559 (2004) 651-662
103. Liddle R.A. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay. Gastroenterol. Clin. North Am. 18 (1989) 735-756
104. Liddle R.A., Green G.M., Conrad C.K., and Williams J.A. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am. J. Physiol. 251 (1986) G243-G248
105. Lipsitz L.A., Pluchino F.C., Wei J.Y., and Rowe J.W. Syncope in institutionalized elderly: the impact of multiple pathological conditions and situational stress. J. Chronic. Dis. 39 (1986) 619-630
106. Lipsitz L.A., Ryan S.M., Parker J.A., Freeman R., Wei J.Y., and Goldberger A.L. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation 87 (1993) 391-400
107. Lovick T.A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats. Pain 21 (1985) 241-252
108. Lucchini S., Saumet J.L., Mei N., and Garnier L. Involvement of the vagus nerve, substance P and cholecystokinin in the regulation of intestinal blood flow. J. Auton. Nerv. Syst. 60 (1996) 182-192
109. Lundberg J.M., Dahlstrom A., Bylock A., Ahlman H., Pettersson G., Larsson I., Hansson H.A., and Kewenter J. Ultrastructural evidence for an innervation of epithelial enterochromaffine cells in the guinea pig duodenum. Acta Physiol. Scand. 104 (1978) 3-12
110. Lundgren O. Sympathetic input into the enteric nervous system. Gut 47 Suppl 4 (2000) iv33-iv35
111. Mark A.L. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J. Am. Coll. Cardiol. 1 (1983) 90-102
112. Marker J.D., and Roberts M.L. Chronotropic actions of cholecystokinin octapeptide on the rat heart. Regul. Pept. 20 (1988) 251-259
113. Martinez M., Hernanz A., Gomez-Cerezo J., Pena J.M., Vazquez J.J., and Arnalich F. Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia. Regul. Pept. 49 (1993) 109-117
114. Masuda Y., and Kawamura A. Role of the autonomic nervous system in postprandial hypotension in elderly persons. J. Cardiovasc. Pharmacol. 42 Suppl 1 (2003) S23-S26
115. Matzinger D., Gutzwiller J.P., Drewe J., Orban A., Engel R., D'Amato M., Rovati L., and Beglinger C. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am. J. Physiol. 277 (1999) R1718-R1724
116. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., D'Amato M., Rovati L., and Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46 (2000) 688-693
117. Mawe G.M. The role of cholecystokinin in ganglionic transmission in the guinea-pig gall-bladder. J. Physiol. (Lond.) 439 (1991) 89-102
118. Mayne R.G., Armstrong W.E., Crowley W.R., and Bealer S.L. Cytoarchitectonic analysis of Fos-immunoreactivity in brainstem neurones following visceral stimuli in conscious rats. J. Neuroendocrinol. 10 (1998) 839-847
119. McLaughlin J.T., Lomax R.B., Hall L., Dockray G.J., Thompson D.{tab}G., and Warhurst G. Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca2+-dependent mechanism in the enteroendocrine cell line STC-1. J. Physiol. (Lond.) 513 Pt 1 (1998) 11-18
120. McLaughlin J., Grazia Luca M., Jones M.N., D'Amato M., Dockray G.J., and Thompson D.G. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116 (1999) 46-53
121. Mei N. Vagal glucoreceptors in the small intestine of the cat. J. Physiol. (Lond.) 282 (1978) 485-506
122. Mei N. Recent studies on intestinal vagal afferent innervation. Functional implications. J. Auton. Nerv. Syst. 9 (1983) 199-206
123. Mei N., and Garnier L. Osmosensitive vagal receptors in the small intestine of the cat. J. Auton. Nerv. Syst. 16 (1986) 159-170
124. Melone J. Vagal receptors sensitive to lipids in the small intestine of the cat. J. Auton. Nerv. Syst. 17 (1986) 231-241
125. Melone J., and Mei N. Intestinal effects of the products of lipid digestion on gastric electrical activity in the cat. Possible involvement of vagal intestinal receptors sensitive to lipids. Gastroenterology 100 (1991) 380-387
126. Mercer J.G., and Lawrence C.B. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve. Neurosci. Lett. 137 (1992) 229-231
127. Miyasaka K., Kanai S., Masuda M., Ibuka T., Nakai K., Fujii N., and Funakoshi A. Involvement of cholinergic processes in cholecystokinin (CCK) release by luminal oleic acid. J. Auton. Nerv. Syst. 63 (1997) 179-182
128. Mobley S.C., Mandel D.A., and Schreihofer A.M. Systemic cholecystokinin differentially affects baro-activated GABAergic neurons in rat caudal ventrolateral medulla. J. Neurophysiol. 96 (2006) 2760-2768
129. Monnikes H., Lauer G., Bauer C., Tebbe J., Zittel T.T., and Arnold R. Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid. Am. J. Physiol. 273 (1997) R2059-R2071
130. Moran T.H., Robinson P.H., Goldrich M.S., and McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain. Res. 362 (1986) 175-179
131. Moran T.H., Smith G.P., Hostetler A.M., and McHugh P.R. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain. Res. 415 (1987) 149-152
132. Moran T.H., Norgren R., Crosby R.J., and McHugh P.R. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain. Res. 526 (1990) 95-102
133. Moriarty P., Dimaline R., Thompson D.G., and Dockray G.J. Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons. Neuroscience 79 (1997) 905-913
134. Mutt V., and Jorpes J.E. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur. J. Biochem. 6 (1968) 156-162
135. Myers E.A., and Rinaman L. Viscerosensory activation of noradrenergic inputs to the amygdala in rats. Physiol. Behav. 77 (2002) 723-729
136. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., and Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am. J. Physiol. 271 (1996) E808-E813
137. Nishizawa M., Nakabayashi H., Uchida K., Nakagawa A., and Niijima A. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J. Auton. Nerv. Syst. 61 (1996) 149-154
138. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781
139. Nyhof R.A., Ingold-Wilcox D., and Chou C.C. Effect of atropine on digested food-induced intestinal hyperemia. Am. J. Physiol. 249 (1985) G685-G690
140. O'Mara G., and Lyons D. Postprandial hypotension. Clin. Geriatr. Med. 18 (2002) 307-321
141. Ormsbee III H.S., and Fondacaro J.D. Action of serotonin on the gastrointestinal tract. Proc. Soc. Exp. Biol. Med. 178 (1985) 333-338
142. Peters J.H., Ritter R.C., and Simasko S.M. Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am. J. Physiol. 290 (2006) R1544-R1549
143. Phifer C.B., and Berthoud H.R. Duodenal nutrient infusions differentially affect sham feeding and Fos expression in rat brain stem. Am. J. Physiol. 274 (1998) R1725-R1733
144. Pirotte B., de Tullio P., Podona T., Diouf O., Dewalque D., Neven P., Masereel B., Caignard P.D., Renard P., and Delarge J. Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation. Eur. J. Pharm. Sci. 7 (1998) 29-40
145. Raybould H.E., and Reeve Jr. J.R. CCK-58: a novel reagent for studying the regulation of cholecystokinin bioactivity. Peptides 17 (1996) 1307-1311
146. Reeve Jr. J.R., Green G.M., Chew P., Eysselein V.E., and Keire D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am. J. Physiol. 285 (2003) G255-G265
147. Reeve Jr. J.R., Wu S.V., Keire D.A., Faull K., Chew P., Solomon T.E., Green G.M., and Coskun T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am. J. Physiol. 286 (2004) G395-G402
148. Reidelberger R.D. Cholecystokinin and control of food intake. J. Nutr. 124 (1994) 1327S-1333S
149. Reidelberger R.D., Castellanos D.A., and Hulce M. Effects of peripheral CCK receptor blockade on food intake in rats. Am. J. Physiol. 285 (2003) R429-R437
150. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J. Neurosci. 23 (2003) 10084-10092
151. Rinaman L., Verbalis J.G., Stricker E.M., and Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J. Comp. Neurol. 338 (1993) 475-490
152. Rinaman L., Hoffman G.E., Dohanics J., Le W.W., Stricker E.M., and Verbalis J.G. Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J. Comp. Neurol. 360 (1995) 246-256
153. Rinaman L., Baker E.A., Hoffman G.E., Stricker E.M., and Verbalis J.G. Medullary c-Fos activation in rats after ingestion of a satiating meal. Am. J. Physiol. 275 (1998) R262-R268
154. Ruiz-Gayo M., Gonzalez M.C., and Fernandez-Alfonso S. Vasodilatory effects of cholecystokinin: new role for an old peptide?. Regul. Pept. 137 (2006) 179-184
155. 3 receptors in the effects of CCK on presympathetic vasomotor neuronal discharge in the rat. Br. J. Pharmacol. 139 (2003) 415-423
156. Salo L.M., Woods R.L., Anderson C.R., and McAllen R.M. Nonuniformity in the von Bezold-Jarisch reflex. Am. J. Physiol. 293 (2007) R714-R720
157. Sanchez-Fernandez C., Gonzalez M.C., Beart P.M., Mercer L.D., Ruiz-Gayo M., and Fernandez-Alfonso M.S. A novel role for cholecystokinin: regulation of mesenteric vascular resistance. Regul. Pept. 121 (2004) 145-153
158. Sankaran H., Deveney C.W., Goldfine I.D., and Williams J.A. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay. J. Biol. Chem. 254 (1979) 9349-9351
159. Sartor D.M., and Verberne A.J.M. Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. Am. J. Physiol. 282 (2002) R1174-R1184
160. Sartor D.M., and Verberne A.J.M. Phenotypic identification of rat rostroventrolateral medullary presympathetic vasomotor neurons inhibited by exogenous cholecystokinin. J. Comp. Neurol. 465 (2003) 467-479
161. Sartor D.M., and Verberne A.J. The sympathoinhibitory effects of systemic cholecystokinin are dependent on neurons in the caudal ventrolateral medulla in the rat. Am. J. Physiol. 291 (2006) R1390-R1398
162. Sartor D.M., Shulkes A., and Verberne A.J. An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats. Am. J. Physiol. 290 (2006) R625-R633
163. Sartor D.M., and Verberne A.J. The role of NMDA and non-NMDA receptors in the NTS in mediating three distinct sympathoinhibitory reflexes. N.-S. Arch. Pharmacol. 376 (2007) 241-252
164. Schreihofer A.M., and Guyenet P.G. Sympathetic reflexes after depletion of bulbospinal catecholaminergic neurons with anti-D beta H-saporin. Am. J. Physiol. 279 (2000) R729-R742
165. Schreihofer A.M., and Guyenet P.G. The baroreflex and beyond: control of sympathetic vasomotor tone by GABAergic neurons in the ventrolateral medulla. Clin. Exp. Pharmacol. Physiol. 29 (2002) 514-521
166. Schreihofer D.A., Cameron J.L., Verbalis J.G., and Rinaman L. Cholecystokinin induces Fos expression in catecholaminergic neurons of the macaque monkey caudal medulla. Brain Res. 770 (1997) 37-44
167. Schultz H.D. Cardiac vagal chemosensory afferents. Function in pathophysiological states. Ann. N. Y. Acad. Sci. 940 (2001) 59-73
168. Schwartz G.J., and Moran T.H. Sub-diaphragmatic vagal afferent integration of meal-related gastrointestinal signals. Neurosci. Biobehav. Rev. 20 (1996) 47-56
169. Schwartz G.J., and Moran T.H. Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am. J. Physiol. 274 (1998) R1236-R1242
170. Schwartz G.J., Moran T.H., White W.O., and Ladenheim E.E. Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ. Am. J. Physiol. 272 (1997) R1726-R1733
171. Scrogin K.E., Veelken R., and Johnson A.K. Central methysergide prevents renal sympathoinhibition and bradycardia during hypotensive hemorrhage. Am. J. Physiol. 43 (1998) H43-H51
172. Sendur R., Czarnobilski K., Pawlik W.W., and Konturek S.J. The role of cholecystokinin in the regulation of intestinal blood circulation and metabolism. Folia Med. Crac. 31 (1990) 5-16
173. Sidery M.B. Meals lie heavy on the heart. J. R. Coll. Physicians Lond. 28 (1994) 19-23
174. Sieber C., Beglinger C., Jaeger K., Hildebrand P., and Stalder G.A. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut 32 (1991) 361-366
175. Sieber C.C., Beglinger C., Bart S., Tschoepl M., Currie G., Larsen F., and Drewe J. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion. Clin. Pharmacol. Ther. 75 (2004) 70-79
176. Smith G.P., and Gibbs J. Satiating effect of cholecystokinin. Ann. N. Y. Acad. Sci. 713 (1994) 236-241
177. Smith G.P., Jerome C., Cushin B.J., Eterno R., and Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213 (1981) 1036-1037
178. Smith G.P., Jerome C., and Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am. J. Physiol. 249 (1985) R638-R641
179. Smith G.T., Moran T.H., Coyle J.T., Kuhar M.J., O'Donahue T.L., and McHugh P.R. Anatomic localization of cholecystokinin receptors to the pyloric sphincter. Am. J. Physiol. 246 (1984) R127-R130
180. Spannagel A.W., Reeve Jr. J.R., Greeley Jr. G.H., Yanaihara N., Liddle R.A., and Green G.M. Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor (LCRF). Regul. Pept. 73 (1998) 161-164
181. Staszewska-Barczak J. Prostanoids and cardiac reflexes of sympathetic and vagal origin. Am. J. Cardiol. 52 (1983) 36A-45A
182. Sullivan C.N., Raboin S.J., Gulley S., Sinzobahamvya N.T., Green G.M., Reeve Jr. J.R., and Sayegh A.I. Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. Am. J. Physiol. 292 (2007) R1071-R1080
183. Szecowka J., Hallden G., Goldfine I.D., and Williams J.A. Purification of the pancreatic cholecystokinin receptor. Regul. Pept. 24 (1989) 215-224
184. Talkad V.D., Fortune K.P., Pollo D.A., Shah G.N., Wank S.A., and Gardner J.D. Direct demonstration of three different states of the pancreatic cholecystokinin receptor. Proc. Nat. Acad. Sci. U. S. A. 91 (1994) 1868-1872
185. Talkad V.D., Patto R.J., Metz D.C., Turner R.J., Fortune K.P., Bhat S.T., and Gardner J.D. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Biochim. Biophys. Acta 1224 (1994) 103-116
186. Tarasova N., Spannagel A.W., Green G.M., Gomez G., Reed J.T., Thompson J.C., Hellmich M.R., Reeve Jr. J.R., Liddle R.A., and Greeley Jr. G.H. Distribution and localization of a novel cholecystokinin-releasing factor in the rat gastrointestinal tract. Endocrinology 138 (1997) 5550-5554
187. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79 (1999) 1-71
188. Van der Plas J., Maes F.W., and Bohus B. Electrophysiological analysis of midbrain periaqueductal gray influence on cardiovascular neurons in the ventrolateral medulla oblongata. Brain Res. Bull. 38 (1995) 447-456
189. Van der Plas J., Wiersingapost J.E.C., Maes F.W., and Bohus B. Cardiovascular effects and changes in midbrain periaqueductal gray neuronal activity induced by electrical stimulation of the hypothalamus in the rat. Brain Res. Bull. 37 (1995) 645-656
190. Vatner S.F., Franklin D., and Van Citters R.L. Mesenteric vasoactivity associated with eating and digestion in the conscious dog. Am. J. Physiol. 219 (1970) 170-174
191. Veelken R., Sawin L.L., and DiBona G.F. Epicardial serotonin receptors in circulatory control in conscious Sprague-Dawley rats. Am. J. Physiol. 258 (1990) H466-H472
192. Verberne A.J.M., and Struyker Boudier H.A. Midbrain central grey: regional haemodynamic control and excitatory amino acidergic mechanisms. Brain. Res. 550 (1991) 86-94
193. Verberne A.J.M., and Guyenet P.G. Medullary pathway of the Bezold-Jarisch reflex in the rat. Am. J. Physiol. 263 (1992) R1195-R1202
194. Verberne A.J.M., and Guyenet P.G. Midbrain central gray: influence on medullary sympathoexcitatory neurons and the baroreflex in rats. Am. J. Physiol. 263 (1992) R24-R33
195. Verberne A.J.M., and Sartor D.M. Cholecystokinin-induced inhibition of presympathetic vasomotor neurons: dependence on sub-diaphragmatic vagal afferents and central NMDA receptors in the rat. Am. J. Physiol. 287 (2004) R809-R816
196. Verberne A.J., Saita M., and Sartor D.M. Chemical stimulation of vagal afferent neurons and sympathetic vasomotor tone. Brain Res. Rev. 41 (2003) 288-305
197. Viltart O., Sartor D.M., and Verberne A.J. Chemical stimulation of visceral afferents activates medullary neurones projecting to the central amygdala and periaqueductal grey. Brain Res. Bull. 71 (2006) 51-59
198. Wang H., Germanson T.P., and Guyenet P.G. Depressor and tachypneic responses to chemical stimulation of the ventral respiratory group are reduced by ablation of neurokinin-1 receptor-expressing neurons. J. Neurosci. 22 (2002) 3755-3764
199. Wang J., Rong W., Hou G., Wang W., and Yuan W. Evidence that NMDA receptors mediate the responses of putative RVLM presympathetic neurons to vagal afferent stimulation in rats. J. Auton. Nerv. Syst. 73 (1998) 93-100
200. Wang L., Cardin S., Martinez V., Tache Y., and Lloyd K.C. Duodenal loading with glucose induces fos expression in rat brain: selective blockade by devazepide. Am. J. Physiol. 277 (1999) R667-R674
201. Widdop R.E., Krstew E., Mercer L.D., Carlberg M., Beart P.M., and Jarrott B. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia. J. Auton. Nerv. Syst. 46 (1994) 65-73
202. Yamamoto M., Reeve Jr. J.R., Keire D.A., and Green G.M. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58, but not by CCK-8. Am. J. Physiol. 287 (2004) G326-G333
203. Zavros Y., and Shulkes A. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. J. Physiol. (Lond.) 505 Pt 3 (1997) 811-821
204. Zhu J.X., Zhu X.Y., Owyang C., and Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J. Physiol. (Lond.) 530 (2001) 431-442
205. Zinner M.J., Kasher F., and Jaffe B.M. The hemodynamic effects of intravenous infusions of serotonin in conscious dogs. J. Surg. Res. 34 (1983) 171-178
206. Zittel T.T., De Giorgio R., Sternini C., and Raybould H.E. Fos protein expression in the nucleus of the solitary tract in response to intestinal nutrients in awake rats. Brain Res. 663 (1994) 266-270
207. Zucker I.H., Panzenbeck M.J., Barker S., Tan W., and Hajdu M.A. PGI2 attenuates baroreflex control of renal nerve activity by a vagal mechanism. Am. J. Physiol. 254 (1988) R424-R430